RDT in Antibiotic Research

The industrial antibiotic yield has been enhanced by technological innovations and the development of strain improvement of microorganisms through random mutation and screening. The recombinant DNA technology and its application in antibiotic production by microorganisms have given yield enhancement and design of biosynthetic pathways for new antibiotic production. Genetic manipulation of biosynthetic pathways is very useful process for producing antagonistic products of complex bioactive metabolites.

 

 

    Related Conference of RDT in Antibiotic Research

    September 08-09, 2025

    45th Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    October 06-07, 2025

    37th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada

    RDT in Antibiotic Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in